
Experts discuss how CDC opioid guidelines reduced prescribing but led to misapplication, affecting patient care and access to pain treatment.

Kerry Schwarz, PharmD, MPH, is a senior clinical manager for evidence-based medicine and outcomes with the Vizient Center for Pharmacy Practice Excellence (CPPE), where she serves as a subject matter expert on formulary management and pharmaceutical outcomes research with an interest in neurosciences. A graduate of the University of North Carolina at Chapel Hill and the Harvard School of Public Health, Kerry completed a PGY1 residency at the University of California, Davis Medical Center, and has spent her career in various leadership roles in healthcare system pharmacy and therapeutics committees, research settings, and residency programs.

Experts discuss how CDC opioid guidelines reduced prescribing but led to misapplication, affecting patient care and access to pain treatment.